Italian Network MDS Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-106
SponsorFondazione Italiana Sindromi Mielodisplastiche-ETS
About this trial
Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
New diagnosis of MDS
Disqualifiers
Patient who refuse the signature of informed consent
Trial population
Patient with new diagnosis of MDS
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Incidence of MDS diagnosis
Number of new cases every 100.000 person/year
Time frame
6 years2
Overall Response rate
Proportion of CR or PR after each line of treatment in term of erythroid, platelet and granulocyte response
Time frame
6 years3
Prevalence of MDS
Number of cases every 100.000 person
Time frame
6 years4
Overall survival
Time between MDS diagnosis and death due to any causes
Time frame
6 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov